On track to deliver 100 million Covid-19 vaccine doses by Q1: Moderna

The company, which signed a purchase agreement with the United States for 200 million doses, said it has supplied 30.4 million doses of its vaccine so far

Moderna
About 10.1 million of the doses have been administered, according to the US Centers for Disease Control and Prevention
Reuters
1 min read Last Updated : Jan 26 2021 | 8:05 PM IST
Moderna Inc said on Tuesday it was on track to deliver about 100 million doses of its Covid-19 vaccine to the United States by the end of the first quarter of 2021, with 200 million doses in total available by the end of the next three months.
 
The company, which signed a purchase agreement with the United States for 200 million doses, said it has supplied 30.4 million doses of its vaccine so far. About 10.1 million of the doses have been administered, according to the US Centers for Disease Control and Prevention.

Moderna said earlier this month it would produce at least 600 million doses of its Covid-19 vaccine in 2021, up by 100 million doses from its previous forecast. It said it was continuing to invest and add staff to build up to potentially 1 billion doses for 2021.
 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirus VaccineUnited States

Next Story